Edition:
United Kingdom

Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

86.24USD
8:40pm BST
Change (% chg)

$0.51 (+0.59%)
Prev Close
$85.73
Open
$85.69
Day's High
$86.32
Day's Low
$85.52
Volume
530,112
Avg. Vol
917,853
52-wk High
$89.01
52-wk Low
$64.25

Chart for

About

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.... (more)

Overall

Beta: 0.35
Market Cap(Mil.): $95,874.12
Shares Outstanding(Mil.): 1,100.99
Dividend: 0.52
Yield (%): 2.39

Financials

  Industry Sector
P/E (TTM): -- 30.44 16.24
EPS (TTM): -- -- --
ROI: -- 14.17 10.90
ROE: -- 15.52 14.09

BRIEF-Novo Nordisk VP says seeks market share from Eli Lilly with semaglutide

Oct 19 NOVO NORDISK CHIEF SCIENTIFIC OFFICER MADS KROGSGAARD THOMSEN SAYS IN INTERVIEW:

7:45am BST

BRIEF-Eli Lilly ‍declares Q4 dividend of $0.52/share

* Declared a dividend for Q4 of 2017 of $0.52 per share on outstanding common stock​ Source text for Eikon: Further company coverage:

16 Oct 2017

BRIEF-Eli Lilly sets quarterly dividend of $0.52 per share

* Sets quarterly dividend of $0.52 per share Source text for Eikon: Further company coverage:

16 Oct 2017

BRIEF-‍BIOLOGICS SAYS SELECTED BY ELI LILLY TO BE IN LIMITED DISTRIBUTION NETWORK FOR VERZENIO​

* ‍BIOLOGICS INC SAYS HAS BEEN SELECTED BY ELI LILLY AND COMPANY TO BE IN LIMITED DISTRIBUTION NETWORK FOR VERZENIO​ Source text for Eikon: Further company coverage:

11 Oct 2017

BRIEF-U.S. PTO rules in Eli Lilly's favor on Alimta

* Patent trial and appeal board of U.S. PTO ruled in company's favor regarding patentability of vitamin regimen for Alimta

05 Oct 2017

BRIEF-Eli lilly says Lilly Endowment Inc reports open market sale of 205,000 shares of co's common stock on Oct. 4

* Eli lilly and co says Lilly Endowment Inc reports open market sale of 205,000 shares of co's common stock on OCT. 4 at average price of $86.805 per share - SEC filing Source text for Eikon: Further company coverage:

05 Oct 2017

BRIEF-Eli Lilly's ‍Humalog Junior Kwikpen now available by prescription in U.S.​

* Eli Lilly and Co - ‍Humalog Junior Kwikpen now available by prescription for treatment of diabetes in U.S.​ Source text for Eikon: Further company coverage:

04 Oct 2017

BRIEF-Eli lilly says lilly endowment reports open market sale of co's common stock

* Eli Lilly And Co says Lilly Endowment Inc reports open market sale of 162,557 shares of co's common stock at average of $85.1/shr‍​ on Sept 29 - sec filing

02 Oct 2017

FDA approves Novo Nordisk fast-acting insulin Fiasp

The U.S. Food and Drug Administration on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.

29 Sep 2017

U.S. FDA approves Novo Nordisk fast-acting insulin Fiasp

Sept 29 The U.S. Food and Drug Administration on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.

29 Sep 2017

Competitors

Earnings vs. Estimates